Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
Clinical trial NCT01037205 · COMPLETED
Trial details
- NCT number
- NCT01037205
- Sponsor
- Ansun Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.